Details for Patent: 12,703,682
Which drugs does patent 12,703,682 protect, and when does it expire?
Patent 12,703,682 protects SOFDRA and is included in one NDA.
This patent has twenty-four patent family members in seventeen countries.
Summary for Patent: 12,703,682
| Title: | Crystalline form of sofpironium bromide and preparation method thereof |
| Abstract: | A cocrystal containing the 1′R-diastereomer and the 1′S-diastereomer of sofpironium bromide at a ratio of 1:3 (Form CO), a crystal mixture (for example, Form B) containing Form CO and a crystalline form of the 1′R-diastereomer (Form MN), and a method for preparing sofpironium bromide, which is suitable for manufacture of the crystal mixture are provided. Form CO and a crystalline form of sofpironium bromide containing Form CO (for example, Form B) have superior stability without hygroscopic property, and accordingly they can be preferably used as a raw material of medicaments. |
| Inventor(s): | Kazuyoshi MARUBAYASHI, Masahito Watanabe, Herbert R. Brinkman |
| Assignee: | Botanix Sb Inc , Kaken Pharmaceutical Co Ltd |
| Application Number: | US17/611,158 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 12,703,682
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Botanix Sb | SOFDRA | sofpironium bromide | GEL, METERED;TOPICAL | 217347-001 | Jun 18, 2024 | RX | Yes | Yes | 12,703,682 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,703,682
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020277881 | ⤷ Start Trial | |||
| Brazil | 112021023241 | ⤷ Start Trial | |||
| Canada | 3139948 | ⤷ Start Trial | |||
| Chile | 2021003047 | ⤷ Start Trial | |||
| China | 114008023 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
